Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Hybrid QM/MM vs Pure MM Molecular Dynamics for Evaluating Water Distribution within p21N-ras and the Resulting GTP Electronic Density.

Tichauer RH, Favre G, Cabantous S, Brut M.

J Phys Chem B. 2019 May 9;123(18):3935-3944. doi: 10.1021/acs.jpcb.9b02660. Epub 2019 Apr 25.

PMID:
30991803
2.

Demethylation by low-dose 5-aza-2'-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma.

Desjobert C, Carrier A, Delmas A, Marzese DM, Daunay A, Busato F, Pillon A, Tost J, Riond J, Favre G, Etievant C, Arimondo PB.

Clin Epigenetics. 2019 Jan 16;11(1):9. doi: 10.1186/s13148-018-0600-2.

3.

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

Keller L, Guibert N, Casanova A, Brayer S, Farella M, Delaunay M, Gilhodes J, Martin E, Balagué G, Favre G, Pradines A, Meyer N.

Acta Derm Venereol. 2019 Feb 1;99(2):206-210. doi: 10.2340/00015555-3080.

4.

Water Distribution within Wild-Type NRas Protein and Q61 Mutants during Unrestrained QM/MM Dynamics.

Tichauer RH, Favre G, Cabantous S, Landa G, Hemeryck A, Brut M.

Biophys J. 2018 Oct 16;115(8):1417-1430. doi: 10.1016/j.bpj.2018.07.042. Epub 2018 Aug 28.

PMID:
30224050
5.

PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.

Mouly L, Mamouni K, Gence R, Cristini A, Cherier J, Castinel A, Legrand M, Favre G, Sordet O, Monferran S.

Cell Death Dis. 2018 Sep 12;9(9):931. doi: 10.1038/s41419-018-0981-3.

6.

Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity.

Calvayrac O, Nowosad A, Cabantous S, Lin LP, Figarol S, Jeannot P, Serres MP, Callot C, Perchey RT, Creff J, Taranchon-Clermont E, Rouquette I, Favre G, Pradines A, Manenti S, Mazieres J, Lee H, Besson A.

J Pathol. 2019 Jan;247(1):60-71. doi: 10.1002/path.5167. Epub 2018 Dec 11.

PMID:
30206932
7.

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.

Guibert N, Delaunay M, Lusque A, Boubekeur N, Rouquette I, Clermont E, Mourlanette J, Gouin S, Dormoy I, Favre G, Mazieres J, Pradines A.

Lung Cancer. 2018 Jun;120:108-112. doi: 10.1016/j.lungcan.2018.04.001. Epub 2018 Apr 3.

PMID:
29748004
8.

[The Ras-related GTPase RhoB, a relevant actor in the adaptive resistance to EGFR tyrosine kinase inhibitors in lung cancers].

Calvayrac O, Pradines A, Mazières J, Favre G.

Med Sci (Paris). 2018 Jan;34(1):12-14. doi: 10.1051/medsci/20183401003. Epub 2018 Jan 31. French. No abstract available.

9.

High-content tripartite split-GFP cell-based assays to screen for modulators of small GTPase activation.

Koraïchi F, Gence R, Bouchenot C, Grosjean S, Lajoie-Mazenc I, Favre G, Cabantous S.

J Cell Sci. 2018 Jan 8;131(1). pii: jcs210419. doi: 10.1242/jcs.210419.

10.

Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma.

Guibert N, Mazieres J, Delaunay M, Casanova A, Farella M, Keller L, Favre G, Pradines A.

Oncotarget. 2017 Jun 6;8(23):38056-38060. doi: 10.18632/oncotarget.16935.

11.

Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion.

Ziani L, Safta-Saadoun TB, Gourbeix J, Cavalcanti A, Robert C, Favre G, Chouaib S, Thiery J.

Oncotarget. 2017 Mar 21;8(12):19780-19794. doi: 10.18632/oncotarget.15540.

12.

The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.

Calvayrac O, Mazières J, Figarol S, Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M, Clermont-Taranchon E, Milia J, Rouquette I, Guibert N, Lusque A, Cadranel J, Mathiot N, Savina A, Pradines A, Favre G.

EMBO Mol Med. 2017 Feb;9(2):238-250. doi: 10.15252/emmm.201606646.

13.

RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers.

Calvayrac O, Pradines A, Favre G.

Small GTPases. 2018 Jul 4;9(4):339-344. doi: 10.1080/21541248.2016.1234429. Epub 2016 Nov 1. Review.

14.

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

Guibert N, Pradines A, Farella M, Casanova A, Gouin S, Keller L, Favre G, Mazieres J.

Lung Cancer. 2016 Oct;100:1-4. doi: 10.1016/j.lungcan.2016.07.021. Epub 2016 Jul 22.

PMID:
27597273
15.

NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Moutel S, Bery N, Bernard V, Keller L, Lemesre E, de Marco A, Ligat L, Rain JC, Favre G, Olichon A, Perez F.

Elife. 2016 Jul 19;5. pii: e16228. doi: 10.7554/eLife.16228.

16.

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.

Guibert N, Pradines A, Casanova A, Farella M, Keller L, Soria JC, Favre G, Mazières J.

J Thorac Oncol. 2016 Sep;11(9):e109-12. doi: 10.1016/j.jtho.2016.05.001. Epub 2016 May 7. No abstract available.

17.

hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression.

Cammas A, Lacroix-Triki M, Pierredon S, Le Bras M, Iacovoni JS, Teulade-Fichou MP, Favre G, Roché H, Filleron T, Millevoi S, Vagner S.

Oncotarget. 2016 Mar 29;7(13):16793-805. doi: 10.18632/oncotarget.7589.

18.

Melanoma-expressed CD70 is involved in invasion and metastasis.

Pich C, Sarrabayrouse G, Teiti I, Mariamé B, Rochaix P, Lamant L, Favre G, Maisongrosse V, Tilkin-Mariamé AF.

Br J Cancer. 2016 Jan 12;114(1):63-70. doi: 10.1038/bjc.2015.412. Epub 2015 Dec 15.

19.

DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.

Cristini A, Park JH, Capranico G, Legube G, Favre G, Sordet O.

Nucleic Acids Res. 2016 Feb 18;44(3):1161-78. doi: 10.1093/nar/gkv1196. Epub 2015 Nov 17.

20.

In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.

Teiti I, Florie B, Pich C, Gence R, Lajoie-Mazenc I, Rochaix P, Favre G, Tilkin-Mariamé AF.

Front Oncol. 2015 Jul 14;5:156. doi: 10.3389/fonc.2015.00156. eCollection 2015.

Supplemental Content

Loading ...
Support Center